380 related articles for article (PubMed ID: 27714575)
1. AGEs/sRAGE, a novel risk factor in the pathogenesis of end-stage renal disease.
Prasad K; Dhar I; Zhou Q; Elmoselhi H; Shoker M; Shoker A
Mol Cell Biochem; 2016 Dec; 423(1-2):105-114. PubMed ID: 27714575
[TBL] [Abstract][Full Text] [Related]
2. Modulation of soluble receptor for advanced glycation end products isoforms and advanced glycation end products in long-living individuals.
Scavello F; Tedesco CC; Castiglione S; Maciag A; Sangalli E; Veglia F; Spinetti G; Puca AA; Raucci A
Biomark Med; 2021 Aug; 15(11):785-796. PubMed ID: 34236256
[TBL] [Abstract][Full Text] [Related]
3. Elevated endogenous secretory receptor for advanced glycation end products (esRAGE) levels are associated with circulating soluble RAGE levels in diabetic children.
Saito R; Araki S; Yamamoto Y; Kusuhara K
J Pediatr Endocrinol Metab; 2017 Jan; 30(1):63-69. PubMed ID: 27941172
[TBL] [Abstract][Full Text] [Related]
4. Modulation of soluble receptor for advanced glycation end-products (RAGE) isoforms and their ligands in healthy aging.
Scavello F; Zeni F; Tedesco CC; Mensà E; Veglia F; Procopio AD; Bonfigli AR; Olivieri F; Raucci A
Aging (Albany NY); 2019 Mar; 11(6):1648-1663. PubMed ID: 30903794
[TBL] [Abstract][Full Text] [Related]
5. Soluble Receptor for Advanced Glycation End Products and Its Forms in COVID-19 Patients with and without Diabetes Mellitus: A Pilot Study on Their Role as Disease Biomarkers.
Dozio E; Sitzia C; Pistelli L; Cardani R; Rigolini R; Ranucci M; Corsi Romanelli MM
J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33238596
[TBL] [Abstract][Full Text] [Related]
6. Cleaved but not endogenous secretory RAGE is associated with outcome in acute ischemic stroke.
Tang SC; Yeh SJ; Tsai LK; Hu CJ; Lien LM; Peng GS; Yang WS; Chiou HY; Jeng JS
Neurology; 2016 Jan; 86(3):270-6. PubMed ID: 26683643
[TBL] [Abstract][Full Text] [Related]
7. Low levels of serum soluble receptors for advanced glycation end products, biomarkers for disease state: myth or reality.
Prasad K
Int J Angiol; 2014 Mar; 23(1):11-6. PubMed ID: 24627612
[TBL] [Abstract][Full Text] [Related]
8. Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 Diabetes.
Lee AC; Lam JK; Shiu SW; Wong Y; Betteridge DJ; Tan KC
PLoS One; 2015; 10(9):e0137330. PubMed ID: 26325204
[TBL] [Abstract][Full Text] [Related]
9. Circulating levels of AGEs and soluble RAGE isoforms are associated with all-cause mortality and development of cardiovascular complications in type 2 diabetes: a retrospective cohort study.
Sabbatinelli J; Castiglione S; Macrì F; Giuliani A; Ramini D; Vinci MC; Tortato E; Bonfigli AR; Olivieri F; Raucci A
Cardiovasc Diabetol; 2022 Jun; 21(1):95. PubMed ID: 35668468
[TBL] [Abstract][Full Text] [Related]
10. Assessment of EN-RAGE, sRAGE, and its isoforms: cRAGE, esRAGE in obese patients treated by moderate caloric restriction combined with physical activity conducted in hospital condition.
Kanikowska D; Kanikowska A; Strojny Z; Kawka E; Zawada A; Rutkowski R; Litwinowicz M; Sato M; Grzymisławski M; Bręborowicz A; Witowski J; Korybalska K
Cytokine; 2024 Aug; 180():156665. PubMed ID: 38823153
[TBL] [Abstract][Full Text] [Related]
11. Two soluble isoforms of receptors for advanced glycation end products (RAGE) in carotid atherosclerosis: the difference of soluble and endogenous secretory RAGE.
Moriya S; Yamazaki M; Murakami H; Maruyama K; Uchiyama S
J Stroke Cerebrovasc Dis; 2014; 23(10):2540-2546. PubMed ID: 25282185
[TBL] [Abstract][Full Text] [Related]
12. Soluble Forms and Ligands of the Receptor for Advanced Glycation End-Products in Patients with Acute Respiratory Distress Syndrome: An Observational Prospective Study.
Jabaudon M; Blondonnet R; Roszyk L; Pereira B; Guérin R; Perbet S; Cayot S; Bouvier D; Blanchon L; Sapin V; Constantin JM
PLoS One; 2015; 10(8):e0135857. PubMed ID: 26274928
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end products (AGEs) and its receptors in the pathogenesis of hyperthyroidism.
Caspar-Bell G; Dhar I; Prasad K
Mol Cell Biochem; 2016 Mar; 414(1-2):171-8. PubMed ID: 26895319
[TBL] [Abstract][Full Text] [Related]
14. The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still's disease.
Chen DY; Chen YM; Lin CC; Hsieh CW; Wu YC; Hung WT; Chen HH; Lan JL
BMC Musculoskelet Disord; 2015 May; 16():111. PubMed ID: 25956266
[TBL] [Abstract][Full Text] [Related]
15. Plasma advanced glycation end products (AGEs), receptors for AGEs and their correlation with inflammatory markers in middle school-age children.
Accacha S; Rosenfeld W; Jacobson A; Michel L; Schnurr FJ; Shelov S; Ten S; Boucher-Berry C; Carey DE; Speiser PW; Lowell B; Conroy R; Klein M; Fennoy I; Rapaport R; Rosenbaum M
Horm Res Paediatr; 2013; 80(5):318-27. PubMed ID: 24217195
[TBL] [Abstract][Full Text] [Related]
16. Advanced Glycation End Products (AGE) and Soluble Forms of AGE Receptor: Emerging Role as Mortality Risk Factors in CKD.
Dozio E; Vettoretti S; Caldiroli L; Nerini-Molteni S; Tacchini L; Ambrogi F; Messa P; Corsi Romanelli MM
Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33371369
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products and soluble receptor as markers of oxidative stress in children on hemodialysis.
El-Saeed GS; Fadel F; Elshamaa MF; Galal RE; Elghoroury EA; Nasr SA; Thabet EH; Abdelrahman SM
Ren Fail; 2015; 37(9):1452-6. PubMed ID: 26337710
[TBL] [Abstract][Full Text] [Related]
18. Soluble receptors for advanced glycation end products and receptor activator of NF-κB ligand serum levels as markers of premature labor.
Rzepka R; Dołęgowska B; Sałata D; Rajewska A; Budkowska M; Domański L; Kwiatkowski S; Mikołajek-Bedner W; Torbé A
BMC Pregnancy Childbirth; 2015 Jun; 15():134. PubMed ID: 26059227
[TBL] [Abstract][Full Text] [Related]
19. The regulation of soluble receptor for AGEs contributes to carbonyl stress in schizophrenia.
Miyashita M; Watanabe T; Ichikawa T; Toriumi K; Horiuchi Y; Kobori A; Kushima I; Hashimoto R; Fukumoto M; Koike S; Ujike H; Arinami T; Tatebayashi Y; Kasai K; Takeda M; Ozaki N; Okazaki Y; Yoshikawa T; Amano N; Washizuka S; Yamamoto H; Miyata T; Itokawa M; Yamamoto Y; Arai M
Biochem Biophys Res Commun; 2016 Oct; 479(3):447-452. PubMed ID: 27641663
[TBL] [Abstract][Full Text] [Related]
20. Circulating soluble RAGE isoforms are attenuated in obese, impaired-glucose-tolerant individuals and are associated with the development of type 2 diabetes.
Miranda ER; Somal VS; Mey JT; Blackburn BK; Wang E; Farabi S; Karstoft K; Fealy CE; Kashyap S; Kirwan JP; Quinn L; Solomon TPJ; Haus JM
Am J Physiol Endocrinol Metab; 2017 Dec; 313(6):E631-E640. PubMed ID: 28811295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
